Is the Pathology of Corticobasal Syndrome Predictable in Life?

Prince of Wales Medical Research Institute, Barker Street, Randwick, New South Wales, Australia
Movement Disorders (Impact Factor: 5.63). 08/2009; 24(11):1593 - 1599. DOI: 10.1002/mds.22558
Source: PubMed

ABSTRACT Corticobasal syndrome (CBS) has been associated with a heterogeneous spectrum of pathologies with an increasing number of reports of Alzheimer's type pathology. There is, however, no means of predicting pathology of CBS in vivo at present. We compared the clinical features of patients presenting with CBS who have either pathologic changes of classic corticobasal degeneration (CBD) or Alzheimer's disease (AD) at post-mortem to identify predictors of the specific pathological processes in life. Twelve patients with CBS were followed prospectively; six had AD and six had classic CBD neuropathology. After review of the presenting clinical features, we identified nine potential predictor variables, compared their frequency in the two groups, and performed a discriminant function analysis. Initial episodic memory complaints and poor performance on the combined orientation-memory subtest of the Addenbrooke's Cognitive Examination (ACE) reliably predicted AD pathology while varying combinations of early frontal-lobe type behavioral symptoms, nonfluent language disturbance, orobuccal apraxia, and utilization behavior predicted CBD pathology ante-mortem. CBS is frequently associated with Alzheimer's disease pathology. Early episodic memory impairment versus early behavioral symptomatology appears to best predict AD or CBD pathology in life. © 2009 Movement Disorder Society

Download full-text


Available from: Thomas H Bak, Dec 19, 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: W zespołach parkinsonowskich objawom ruchowym często towarzyszą zaburzenia poznawcze i emocjonalne. Rozwijają się one przed wystąpieniem pierwszych objawów ruchowych lub po ich wystąpieniu, a ich nasilenie może być łagodne bądź znaczne. Ocena tych zaburzeń ma szczególne znaczenie dla ustalenia rozpoznania, rokowania i planowania dalszego postępowania. W artykule przedstawiono problematykę rozpoznawania i różnicowania zaburzeń poznawczych w atypowych zespołach parkinsonowskich, takich jak postępujące porażenie ponadją-drowe, zespół korowo-podstawny, otępienie czołowo-skroniowe z parkinsonizmem sprzężone z chromosomem 17, otępienie z ciałami Lewy’ego oraz zanik wieloukładowy. Omówiono ogólną charakterystykę tych zaburzeń, cechy różnicujące poszczególne choroby, a także zagadnienia doboru metod do oceny przesiewowej i badania neuropsychologicznego.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Corticobasal syndrome (CBS) is characterized by asymmetric involuntary movements including rigidity, tremor, dystonia, and myoclonus, and often associated with apraxia, cortical sensory deficits, and alien limb phenomena. Additionally, there are various nonmotor (cognitive and language) deficits. CBS is associated with several distinct histopathologies, including corticobasal degeneration, other forms of tau-related frontotemporal lobar degeneration such as progressive supranuclear palsy, and Alzheimer disease. Accurate antemortem diagnosis of underlying pathology in CBS is challenging, though certain clinical and imaging findings may be helpful. Five recent advances in the understanding of CBS are reviewed, including clinical and pathologic features, imaging and CSF biomarkers, the role of specific genes, and the concept of a spectrum of tauopathies.
    Nature Clinical Practice Neurology 08/2014; 4(4):304-312. DOI:10.1212/CPJ.0000000000000026 · 7.64 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: To use the Visual Object and Space Perception Battery (VOSP) to distinguish Alzheimer disease (AD) from non-AD pathology in corticobasal syndrome (CBS).METHODS: This clinicopathologic study assessed 36 patients with CBS on the VOSP. All were autopsied. The primary dependent variable was a binary pathologic outcome: patients with CBS who had primary pathologic diagnosis of AD (CBS-AD, n = 10) vs patients with CBS without primary pathologic diagnosis of AD (CBS-nonAD, n = 26). We also determined sensitivity and specificity of individual VOSP subtests.RESULTS: Patients with CBS-AD had younger onset (54.5 vs 63.6 years, p = 0.001) and lower memory scores on the Mattis Dementia Rating Scale-2 (16 vs 22 points, p = 0.003). Failure on the VOSP subtests Incomplete Letters (odds ratio [OR] 11.5, p = 0.006), Position Discrimination (OR 10.86, p = 0.008), Number Location (OR 12.27, p = 0.026), and Cube Analysis (OR 45.71 p = 0.0001) had significantly greater odds of CBS-AD than CBS-nonAD. These associations remained when adjusting for total Mattis Dementia Rating score, disease laterality, education, age, and sex. Receiver operating characteristic curves demonstrated significant accuracy for Incomplete Letters and all VOSP spatial subtests, with Cube Analysis performing best (area under the curve 0.91, p = 0.0004).CONCLUSIONS: In patients with CBS, failure on specific VOSP subtests is associated with greater odds of having underlying AD. There may be preferential involvement of the dorsal stream in CBS-AD.CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that some subtests of the VOSP accurately distinguish patients with CBS-AD from those without AD pathology (e.g., Cube Analysis sensitivity 100%, specificity 77%).
    Neurology 07/2014; 83(6). DOI:10.1212/WNL.0000000000000667 · 8.30 Impact Factor